SCHEMBL1521208

SCHEMBL1521208

CCOC(NO)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 2/20 0.45
LMNA P02545 2/20 0.42
POLB P06746 3/20 0.41
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 4/20 0.39
KMT2A Q03164 3/20 0.38
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
AOC3 Q16853 1/20 0.37
KDM4E B2RXH2 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MEN1 O00255 2/20 0.36
TSHR P16473 1/20 0.36
ATM Q13315 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21243279 0.83 HTT (0.42) MMP8LMNAPOLBHTTL3MBTL1
SCHEMBL28070949 0.76 L3MBTL1 (0.40) MMP8LMNAPOLBHTTL3MBTL1
SCHEMBL6551729 0.72 L3MBTL1 (0.42) MMP8LMNAPOLBHTTL3MBTL1
SCHEMBL6972092 0.72 L3MBTL1 (0.42) MMP8LMNAPOLBHTTL3MBTL1
SCHEMBL366712 0.72 LMNA (0.52) MMP8LMNAPOLBL3MBTL1KMT2A
SCHEMBL28141556 0.72 MME (0.46) MMP8PPARGPPARA
Hydrochloric Acid SCHEMBL28844529 0.72 SMN1; SMN2 (0.37) MMP8LMNAPOLBHTTL3MBTL1
SCHEMBL3992907 0.72 SCN1A (0.55) LMNAPOLBHTTL3MBTL1KMT2A
SCHEMBL27191 0.72 ACHE (0.47) LMNAPOLBHTTL3MBTL1KDM4E
Dimethylamine SCHEMBL29198789 0.71 HTT (0.55) LMNAHTTL3MBTL1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110053941-A1 IDO Inhibitors NEWLINK GENETICS (US) 2011-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110053941-A1 IDO Inhibitors IDO1, IDO2, INMT MMP8 427/4885LMNA 4872/4885POLB 2747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.